$31.62
2.20% yesterday
Nasdaq, Jun 13, 10:00 pm CET
ISIN
US04963C2098
Symbol
ATRC

AtriCure, Inc. Stock price

$31.62
+0.14 0.44% 1M
-0.05 0.16% 6M
+1.06 3.47% YTD
+10.65 50.79% 1Y
-14.07 30.79% 5Y
+9.18 40.91% 10Y
+17.54 124.57% 20Y
Nasdaq, Closing price Fri, Jun 13 2025
-0.71 2.20%
ISIN
US04963C2098
Symbol
ATRC
Sector

Key metrics

Market capitalization $1.57b
Enterprise Value $1.53b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 3.18
P/S ratio (TTM) P/S ratio 3.26
P/B ratio (TTM) P/B ratio 3.44
Revenue growth (TTM) Revenue growth 15.80%
Revenue (TTM) Revenue $480.08m
EBIT (operating result TTM) EBIT $-35.05m
Free Cash Flow (TTM) Free Cash Flow $-670.00k
Cash position $99.89m
EPS (TTM) EPS $-0.81
P/E forward negative
P/S forward 2.99
EV/Sales forward 2.92
Short interest 3.83%
Show more

Is AtriCure, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

AtriCure, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a AtriCure, Inc. forecast:

9x Buy
100%

Analyst Opinions

9 Analysts have issued a AtriCure, Inc. forecast:

Buy
100%

Financial data from AtriCure, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
480 480
16% 16%
100%
- Direct Costs 121 121
18% 18%
25%
359 359
15% 15%
75%
- Selling and Administrative Expenses 294 294
12% 12%
61%
- Research and Development Expense 97 97
23% 23%
20%
-32 -32
11% 11%
-7%
- Depreciation and Amortization 3.04 3.04
6% 6%
1%
EBIT (Operating Income) EBIT -35 -35
10% 10%
-7%
Net Profit -38 -38
2% 2%
-8%

In millions USD.

Don't miss a Thing! We will send you all news about AtriCure, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

AtriCure, Inc. Stock News

Neutral
Business Wire
22 days ago
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Goldman Sachs 46th Annual Global Healthcare Conference. AtriCure's management is scheduled to host a...
Neutral
Seeking Alpha
about 2 months ago
AtriCure, Inc. (NASDAQ:ATRC ) Q1 2025 Earnings Conference Call April 29, 2025 4:30 PM ET Company Participants Marissa Bych - Investor Relations, Gilmartin Group Michael Carrel - President and Chief Executive Officer Angela Wirick - Chief Financial Officer Conference Call Participants William Plovanic - Canaccord Genuity Matthew O'Brien - Piper Sandler Companies John McAulay - Stifel Financial C...
Neutral
Business Wire
about 2 months ago
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced first quarter 2025 financial results. “Our performance in the first quarter reflects outstanding execution of several new product launches and the strength ...
More AtriCure, Inc. News

Company Profile

AtriCure, Inc. engages development, manufacture and sale of devices designed primarily for the surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio Frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, Other International, and Total International. The company was founded by Michael D. Hooven on October 31, 2000 and is headquartered in West Chester, OH.

Head office United States
CEO Michael Carrel
Employees 1,300
Founded 1994
Website www.atricure.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today